S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

LGND Ligand Pharmaceuticals Incorporated

72.32

0.90 (1.26%)

03 May 2024 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals (NASDAQ:LGND)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Ligand Pharmaceuticals Charts.

Ligand Pharmaceuticals Incorporated News

Form 4 - Statement of changes in beneficial ownership of securities
Friday 8 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 2 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144/A - Report of proposed sale of securities: [Amend]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

More Ligand Pharmaceuticals Incorporated News Articles

AUD vs US Dollar

S&P ASX 300 Metals and M...

Invesco QQQ Trust Series 1

Australia And New Zealan...

Verizon Communications

Newcrest Mining

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions